Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang

Nirmal Bang has come out with its first quarter (April - June’ 24) earnings estimates for the Pharmaceutical sector. The brokerage house expects Zydus Lifescience to report net profit at Rs 839.1 crore up 58.6% year-on-year (up 18.9% quarter-on-quarter).

Net Sales are expected to increase by 24 percent Y-o-Y (up 0.8 percent Q-o-Q) to Rs 5,050.3 crore, according to Nirmal Bang.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 51.6 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs 1,262.6 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.